Shinobi Therapeutics
Developer of cell therapies designed for comprehensive immune evasion. The company is developing a new class of hyperimmune CD8ab iPS-T cells for cancer and other genetic diseases, providing the healt...
Valuation
$0
Share Price
N/A
Total Raised
$78.3M
Last Round
N/A